Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB.
暂无分享,去创建一个
Juan Jiménez | R. El Bekay | J. Monteseirín | F. Sobrino | J. Martín-Nieto | Francisco Sobrino | F. Bedoya | Rajaa El Bekay | Moisés Alvarez | Javier Monteseirín | Gonzalo Alba | Pedro Chacón | Antonio Vega | José Martin-Nieto | Elizabeth Pintado | Francisco J Bedoya | J. Jiménez | A. Vega | P. Chacón | Moisés Alvarez | Gonzalo Alba | E. Pintado | P. Chacón
[1] I. Fridovich,et al. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.
[2] M. Peach. Renin-angiotensin system: biochemistry and mechanisms of action. , 1977, Physiological reviews.
[3] K. Shimada,et al. Binding sites for angiotensin II in human mononuclear leucocytes. , 1978, Journal of biochemistry.
[4] E. Pick,et al. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. , 1980, Journal of immunological methods.
[5] L. Mcphail,et al. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme , 1984, The Journal of experimental medicine.
[6] M. Yeung,et al. Leukocyte count, smoking, and lung function. , 1984, The American journal of medicine.
[7] V. Dzau. Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis. , 1984, The American journal of medicine.
[8] A. Ferrante,et al. Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma. , 1987, Immunology.
[9] E. Melloni,et al. Enhanced activation of the respiratory burst oxidase in neutrophils from hypertensive patients. , 1989, Biochemical and biophysical research communications.
[10] Y. Postnov. An approach to the explanation of cell membrane alteration in primary hypertension. , 1990, Hypertension.
[11] J. Merritt,et al. Rapid kinetics of agonist-evoked changes in cytosolic free Ca2+ concentration in fura-2-loaded human neutrophils. , 1990, The Biochemical journal.
[12] A. Cross. Inhibitors of the leukocyte superoxide generating oxidase: mechanisms of action and methods for their elucidation. , 1990, Free radical biology & medicine.
[13] W. Nauseef,et al. Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. , 1990, The Journal of clinical investigation.
[14] R. Seifert,et al. Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertension. , 1991, Journal of hypertension.
[15] T. Leto,et al. Characterization of neutrophil NADPH oxidase factors p47-phox and p67-phox from recombinant baculoviruses. , 1991, The Journal of biological chemistry.
[16] A. Kraft,et al. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. , 1992, The Journal of biological chemistry.
[17] D. Rotrosen,et al. Regulation of the human neutrophil NADPH oxidase by rho-related G-proteins. , 1993, Biochemistry.
[18] J. Gomez-Cambronero,et al. Direct stimulation by tyrosine phosphorylation of microtubule-associated protein (MAP) kinase activity by granulocyte-macrophage colony-stimulating factor in human neutrophils. , 1993, The Biochemical journal.
[19] U. Das,et al. Are free radicals involved in the pathobiology of human essential hypertension? , 1993, Free radical research communications.
[20] G. Specchia,et al. Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease , 1993, Circulation.
[21] P. Timmermans,et al. Angiotensin II receptors and angiotensin II receptor antagonists. , 1993, Pharmacological reviews.
[22] J. Satriano,et al. Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species. , 1994, The Journal of clinical investigation.
[23] R W Alexander,et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.
[24] S. Grinstein,et al. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils. Role of oxidants. , 1994, The Journal of biological chemistry.
[25] G. Johnson,et al. FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase. , 1994, The Journal of clinical investigation.
[26] K. Kume,et al. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. , 1994, The Journal of biological chemistry.
[27] L. Hunyady,et al. Evidence for participation of calcineurin in potentiation of agonist-stimulated cyclic AMP formation by the calcium-mobilizing hormone, angiotensin II. , 1994, The Journal of biological chemistry.
[28] G. Bokoch,et al. Ras-related GTP-binding proteins and leukocyte signal transduction. , 1994, Current opinion in hematology.
[29] T. Resink,et al. Activation of human peripheral monocytes by angiotensin II , 1994, FEBS letters.
[30] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[31] M. A. Mansfield. Rapid immunodetection on polyvinylidene fluoride membrane blots without blocking. , 1995, Analytical biochemistry.
[32] Philip R. Cohen,et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.
[33] Hua Yu,et al. Dissociation of Mitogen-activated Protein Kinase Activation from the Oxidative Burst in Differentiated HL-60 Cells and Human Neutrophils (*) , 1995, The Journal of Biological Chemistry.
[34] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[35] Qingbo Xu,et al. Activation of Mitogen-activated Protein Kinase by HO , 1996, The Journal of Biological Chemistry.
[36] R. Ulevitch,et al. Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. , 1996, Archives of biochemistry and biophysics.
[37] K. Skrede,et al. Peritoneal leucocytes from spontaneously hypertensive rats have reduced chemiluminescence response and lowered sensitivity to dexamethasone in vivo. , 1996, Acta physiologica Scandinavica.
[38] J. Monteseirín,et al. Enhancement of Antigen-specific functional responses by neutrophils from allergic patients , 1996, The Journal of experimental medicine.
[39] S. Grinstein,et al. Chemotactic Peptide N-formyl-Met-Leu-Phe Activation of p38 Mitogen-activated Protein Kinase (MAPK) and MAPK-activated Protein Kinase-2 in Human Neutrophils* , 1997, The Journal of Biological Chemistry.
[40] A. Takeshita,et al. Angiotensin II Stimulates Mitogen-activated Protein Kinases and Protein Synthesis by a Ras-independent Pathway in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.
[41] V. Koshkin,et al. Inhibition of NADPH Oxidase Activation by 4-(2-Aminoethyl)-benzenesulfonyl Fluoride and Related Compounds* , 1997, The Journal of Biological Chemistry.
[42] IsseiKomuro,et al. Angiotensin II Stimulates c-Jun NH2-Terminal Kinase in Cultured Cardiac Myocytes of Neonatal Rats , 1997 .
[43] S. Grinstein,et al. Inhibition of neutrophil oxidative burst and granule secretion by Wortmannin: Potential role of MAP kinase and renaturable kinases , 1997, Journal of cellular physiology.
[44] J. Zweier,et al. Validation of Lucigenin (Bis-N-methylacridinium) as a Chemilumigenic Probe for Detecting Superoxide Anion Radical Production by Enzymatic and Cellular Systems* , 1998, The Journal of Biological Chemistry.
[45] D. Kreutzer,et al. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. , 1998, Journal of immunology.
[46] M. Karin,et al. Calcineurin preferentially synergizes with PKC‐θ to activate JNK and IL‐2 promoter in T lymphocytes , 1998, The EMBO journal.
[47] J. Klein,et al. Bacterial phagocytosis activates extracellular signal‐regulated kinase and p38 mitogen‐activated protein kinase cascades in human neutrophils , 1998, Journal of leukocyte biology.
[48] K. Catt,et al. Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells. , 1998, Endocrinology.
[49] Annette Gilchrist,et al. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. , 1998, Journal of immunology.
[50] R. Thieringer,et al. Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. , 1998, Journal of immunology.
[51] T. Finkel. Oxygen radicals and signaling. , 1998, Current opinion in cell biology.
[52] R. Alexander,et al. p38 Mitogen-activated Protein Kinase Is a Critical Component of the Redox-sensitive Signaling Pathways Activated by Angiotensin II , 1998, The Journal of Biological Chemistry.
[53] W. Daniel,et al. Involvement of tyrosine kinases, Ca2+ and PKC in activation of mitogen‐activated protein (MAP) kinase in human polymorphonuclear neutrophils , 1998, The Journal of physiology.
[54] J. Nick,et al. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. , 1999, The Journal of clinical investigation.
[55] W. Kübler,et al. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes. , 1999, Biochemical and biophysical research communications.
[56] R. Ross. Atherosclerosis is an inflammatory disease , 1999 .
[57] P. Mannon,et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. , 1999, The Journal of clinical investigation.
[58] J. Monteseirín,et al. Characterization of Calcineurin in Human Neutrophils , 1999, The Journal of Biological Chemistry.
[59] J. Molkentin,et al. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. , 2000, Circulation.
[60] Ling-Chu Chang,et al. Activation of p38 mitogen-activated protein kinase by formyl-methionyl-leucyl-phenylalanine in rat neutrophils. , 2000, European journal of pharmacology.
[61] A. Markham,et al. Irbesartan , 2000, Drugs.
[62] T. Yamakawa,et al. Printed in U.S.A. Copyright © 2000 by The Endocrine Society Involvement of Reactive Oxygen Species in the , 2000 .
[63] Y. Mori,et al. Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase. , 2000, The Journal of biological chemistry.
[64] D. Harrison,et al. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.
[65] L. Mcphail,et al. Phorbol myristate acetate induces neutrophil NADPH‐oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3‐kinase , 2000, Journal of leukocyte biology.
[66] T. Yamakawa,et al. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. , 2000, Endocrinology.
[67] T. Pedrazzini,et al. Calcineurin Blockade Prevents Cardiac Mitogen-activated Protein Kinase Activation and Hypertrophy in Renovascular Hypertension* , 2000, The Journal of Biological Chemistry.
[68] M. Guba,et al. DIFFERENTIAL EFFECTS OF SHORT‐TERM ACE‐ AND AT1‐RECEPTOR INHIBITION ON POSTISCHEMIC INJURY AND LEUKOCYTE ADHERENCE IN VIVO AND IN VITRO , 2000, Shock.
[69] D. Sorescu,et al. NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.
[70] M. Suematsu,et al. ERK and p38 MAPK, but not NF-&kgr;B, Are Critically Involved in Reactive Oxygen Species–Mediated Induction of IL-6 by Angiotensin II in Cardiac Fibroblasts , 2001, Circulation research.
[71] G L Johnson,et al. Tumor necrosis factor-alpha activation of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis. , 2001, The Journal of biological chemistry.
[72] E. Schiffrin,et al. Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells , 2001, Journal of hypertension.
[73] S Eguchi,et al. Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.
[74] Jiahuai Han,et al. Calcineurin Enhances MAPK Phosphatase-1 Expression and p38 MAPK Inactivation in Cardiac Myocytes* , 2001, The Journal of Biological Chemistry.
[75] YoshihikoSaito,et al. ERK and p38 MAPK, but not NF-κB, Are Critically Involved in Reactive Oxygen Species–Mediated Induction of IL-6 by Angiotensin II in Cardiac Fibroblasts , 2001 .
[76] K. Takemori,et al. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury , 2001, Journal of hypertension.
[77] M. Sanz,et al. Reactive oxygen species mediate angiotensin II‐induced leukocyte‐endothelial cell interactions in vivo , 2001, Journal of leukocyte biology.
[78] R. El Bekay,et al. Activation of phagocytic cell NADPH oxidase by norfloxacin: a potential mechanism to explain its bactericidal action , 2002, Journal of leukocyte biology.
[79] D. Mann,et al. Angiotensin II Induces Tumor Necrosis Factor Biosynthesis in the Adult Mammalian Heart Through a Protein Kinase C-Dependent Pathway , 2002, Circulation.
[80] B. Zweiman,et al. Neutrophils , 2019, Nursing Critical Care.
[81] K. Malcolm,et al. A Genomic and Proteomic Analysis of Activation of the Human Neutrophil by Lipopolysaccharide and Its Mediation by p38 Mitogen-activated Protein Kinase* , 2002, The Journal of Biological Chemistry.
[82] Jerry A Nick,et al. A Role for Protein Phosphatase-2A in p38 Mitogen-activated Protein Kinase-mediated Regulation of the c-Jun NH2-terminal Kinase Pathway in Human Neutrophils* , 2002, The Journal of Biological Chemistry.